Observational studyEuropean journal of haematology2019

Survival outcomes in myelofibrosis patients treated with ruxolitinib: A population-based cohort study in Sweden and Norway.

Frida Schain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.